论文部分内容阅读
目的观察痰热清注射液治疗婴幼儿支气管肺炎疗效。方法选择我院2011年1月～2011年12月婴幼儿支气管肺炎患儿112例,随机分为两组,对照组56例患者采用常规抗感染及止咳平喘治疗,观察组56例患者在对照组基础上加用痰热清注射液治疗,观察两组治疗效果、症状改善情况及不良反应。结果观察组显效46例,有效6例,总有效率为92.86%;对照组显效31例,有效14例,总有效率为80.36%;两组比较差异具有显著性,有统计学意义(P<0.05)。比较两组患儿体温正常、痰液正常、咳嗽消失、气喘消失、体征消失时间,观察组均短于对照组,住院时间比较短于对照组,两组比较差异具有显著性,有统计学意义(P<0.05)。结论痰热清注射液治疗婴幼儿支气管肺炎疗效确切,具有较高的安全性,可在临床推广应用。
Objective To observe the effect of Tanreqing injection on bronchopneumonia in infants. Methods 112 cases of infantile bronchopneumonia in our hospital from January 2011 to December 2011 were randomly divided into two groups. 56 cases in the control group were treated with conventional anti-infective and cough-asthma treatment. 56 cases in the observation group were compared with the control group Based on the group with Tanreqing injection treatment, the two groups were observed treatment, symptom improvement and adverse reactions. Results The observation group was effective in 46 cases, effective in 6 cases, the total effective rate was 92.86%; the control group markedly effective in 31 cases, effective in 14 cases, the total effective rate was 80.36%; the difference between the two groups was significant and statistically significant (P < 0.05). Comparing the two groups of children with normal body temperature, normal sputum, cough disappeared, asthma disappeared, signs of disappearance of time, the observation group were shorter than the control group, hospitalization was shorter than the control group, the difference between the two groups was statistically significant (P <0.05). Conclusion Tanreqing Injection for the treatment of infantile bronchopneumonia is effective, with high safety, which can be popularized and applied clinically.